FridayMay 29, 2009 9:41 am

Axial Vector Energy Corp. (AXVC.PK) Targets Energy Efficiency

The Axial Vector Energy Corp. has a lock on technologies that feed into two of the most important fields today: increased engine efficiency for power generation and vehicles, and increased purification efficiency for the processing of oil. Both areas are driven by growing demand for environmental protection, and stand to gain from worldwide governmental support. Axial develops and licenses advanced internal combustion engines and power generator technologies, in addition to supporting a patented sonic energy and oxidation process for the more cost effective removal of sulfur and nitrogen compounds from oil. The company’s prototype GENSET power generation product is designed…

Continue Reading

FridayMay 29, 2009 6:49 am

BakBone Software, Inc. (BKBO.OB) Common Stock Commences Trading on the OTCBB

BakBone Software Inc., a leading provider of Universal Data Management solutions, announced today that, effective immediately, its stock is trading on the OTC Bulletin Board under the ticker symbol “BKBO.” Previously, the company’s stock was traded on the pink sheets. “The move to the OTC Bulletin Board will provide more visibility for our stock and our company with investors and help improve our trading liquidity,” stated Jim Johnson, president and CEO, BakBone. “The OTC Bulletin Board quotation is one more important step in BakBone’s efforts to enhance shareholder value.” Let us hear your thoughts below:

Continue Reading

FridayMay 29, 2009 6:41 am

Shermen WSC Acquisition Corp. (SACQ.OB) Acquires the Westway Bulk Liquid Storage and Liquid Animal Feed Supplement Businesses of ED&F Man Holdings Ltd.

Shermen WSC Acquisition Corp., a special-purpose acquisition company, announced today that it has completed the acquisition of the Westway bulk liquid storage and liquid animal supplement businesses of ED&F Man Holdings Limited. The company also announced that it has changed its name to Westway Group, Inc. Shermen (now known as Westway Group, Inc.) looks forward to setting a record date in the next several days for the previously announced $1.00 per share special dividend payable to each holder of its common stock as of the record date. Peter Harding, Chief Executive Officer, stated, “The management of Westway are very excited…

Continue Reading

FridayMay 29, 2009 5:20 am

Aquentium, Inc. (AQNM.OB) Introduces Non-Chemical Sanitation System

Aquentium, Inc. recently announced the company's new mobile non-chemical sanitation system, The Aquentium MOS-1, designed to eliminate or reduce bacteria and viruses in hospitals, restaurants, hotels, schools and food and beverage processing plants. "Our MOS-1 system utilizes ozone which replaces the need for chemicals and is the natural way to sanitize surfaces and food products. Ozone gas (O3) can be generated by passing high voltage electricity through oxygenated air, causing oxygen to break apart and recombine in the tri-atomic form," stated Aquentium President Mark Taggatz, "We expect that our cost -effective mobile sanitizing system will be of great benefit to…

Continue Reading

FridayMay 29, 2009 5:05 am

Explorations Group, Inc. (EXGI.OB) Appoints Robert McCann as New President and CEO

Explorations Group, Inc., a provider of biometrically based security solutions, recently announced the appointment of Robert E. McCann III as their new President and CEO. Upon the appointment of Mr. McCann, the company's previous President, David Coriaty, became their Executive Chairman. From January 2008 to May 2009, Mr. McCann served as Chairman and Chief Executive Officer of Revolution Forward Consulting Group, a business transformation consulting company. Prior to that position, McCann worked on Wall Street for 14 years as a licensed broker, Investment Advisor Representative, and General Securities Principal. Additionally, Mr. McCann served as a Board Member of a NASDAQ…

Continue Reading

FridayMay 29, 2009 4:54 am

IR BioSciences Holdings, Inc. (IRBS.OB) Subsidiary Announces IND Submission for Homspera® for the Treatment of Idiopathic Pulmonary Fibrosis

ImmuneRegen BioSciences, a development-stage biotechnology company and a wholly owned subsidiary of IR BioSciences Holdings, Inc. (IRBS.OB), announced the company’s submission of an Investigational New Drug Application (IND) to the U.S. Food and Drug Administration (FDA) to begin human clinical testing of Homspera® for the treatment of Idiopathic Pulmonary Fibrosis. Currently afflicting 5 million people worldwide and killing 40,000 people annually, Idiopathic Pulmonary Fibrosis is a progressive interstitial lung disease characterized by scarring of lung tissue and over time prevents the lung from effectively transferring oxygen into the bloodstream. Homspera® is an adult stem cell active compound that has shown…

Continue Reading

ThursdayMay 28, 2009 6:52 am

Power Medical Interventions® (PMII.OB) Receives 510(k) Clearance to Market iDrive Intelligent Power Unit™ with iConsole™

Power Medical Interventions®, Inc. (PMII.OB), the world's only provider of computer-assisted, power-actuated surgical cutting and stapling products, announced yesterday that the company has received clearance from the U.S. Food and Drug Administration (FDA) for its 510(k) application for marketing iDrive Intelligent Power Unit™, a detachable Intelligent Surgical Instruments and iConsole™. As a leader in developing and commercializing Intelligent Surgical Instruments™, Power Medical Interventions intends to launch the iDrive, Intelligent Surgical Instruments and iConsole products for commercial sale, effective immediately. The iDrive is designed to support a variety of minimally invasive procedures by offering surgeons a broad range of cutting configurations…

Continue Reading

ThursdayMay 28, 2009 6:08 am

Cytori Therapeutics (CYTX) Announces Publication of Cardiovascular Preclinical Study

Cytori Therapeutics announced today before the opening bell that the first preclinical study to demonstrate adipose-derived stem and regenerative cells (ADRCs) significantly improved cardiac function after a heart attack has been published. This preclinical study was reported online ahead of print in the International Journal of Cardiology. Funded by Cytori Therapeutics, the study was conducted at Tulane University. “Treatment of cardiovascular disease, which places one of the greatest burdens on our healthcare system, could be revolutionized by cell therapy,” stated Marc H. Hedrick, M.D., president of Cytori. “We observed a statistically significant improvement in heart function that contributed to our…

Continue Reading

WednesdayMay 27, 2009 12:30 pm

Solar Energy Initiatives, Inc. (SNRY.OB) is Committed to Revolutionizing the Energy Industry

Solar Energy Initiatives was founded with the purpose of executing a grass roots campaign, “RENEW THE NATION”, to help redeploy a portion of the U.S. work force and reduce the world’s dependence on fossil fuels by selling solar thermal and photovoltaic (PV) technologies. Since acquiring the assets of Solar Energy, Inc. last year, the company has rapidly expanded its dealership network bringing many newly trained solar contractors to the growing marketplace. Solar Energy Initiatives aims to integrate and sell solar thermal and photovoltaic technologies while building a profitable company. Although the company's focus is on providing wholesale solar equipment to…

Continue Reading

WednesdayMay 27, 2009 9:26 am

Axial Vector Energy Corp. (AXVC.PK) Recruits Muse Stancil for Independent Review of Crude Oil Upgrading Technology

Axial Vector Energy Corp. (AVEC) focuses on the international engine and global energy markets by providing technology solutions for military, industrial and commercial applications. The company earlier this month announced that Muse Stancil will execute an independent review for AVEC’s Oxidating Desulphurization and Heavy Crude Oil Upgrading technology, which the company acquired through its joint venture (PETRO AVEC) with Petrosonics LLC. Muse Stancil is a global consulting firm, focused on the energy industry, offering solutions for a variety of issues. Per its agreement with AVEC, Muse Stancil will evaluate the technology to determine the most effective commercialization strategy, as well…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered